200 mg GILEAD (Emtriva 200 mg)

Generic Name: emtricitabine

This pill with imprint "200 mg GILEAD" is Blue & White, Capsule-shape and has been identified as Emtriva 200 mg. It is manufactured by Gilead Sciences.

Emtriva is used in the treatment of occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Emtriva 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Emtriva

Generic Name:

emtricitabine

Imprint:

200 mg GILEAD

Strength:

200 mg

Color:

Blue & White

Size:

19.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Gilead Sciences

National Drug Code (NDC):

61958-0601

Inactive Ingredients:

microcrystalline cellulose
crospovidone
povidone
magnesium stearate
water
FD&C Blue No. 2
titanium dioxide
gelatin

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
54868-4853	Physicians Total Care Inc (repackager)
54569-5521	A-S Medication Solutions, LLC (repackager)
35356-0205	Lake Erie Medical and Surgical Supply (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.